Supporting new ideas in cancer drug discovery and development
The cancer center is committed to supporting projects with the potential to bring new drugs to clinic.
In order to facilitate projects moving to patients more quickly, the CD3A Pilot offers support to perform assays and experiments that will move the project closer to the next milestone. Awards require the use of an IU or IUSCCC core. Additionally, PIs have the opportunity to meet with drug development consultants to determine next steps and troubleshoot difficulties.